Sarah E Flanagan1, Ann-Marie Patch, Sian Ellard. 1. Institute of Biomedical and Clinical Science, Peninsula Medical School, University of Exeter, Exeter, United Kingdom. sarah.flanagan@pms.ac.uk
Abstract
CONTEXT: The interpretation of novel missense variants is a challenge with increasing numbers of such variants being identified and a responsibility to report the findings in the context of all available scientific evidence. Various in silico bioinformatic tools have been developed that predict the likely pathogenicity of missense variants; however, their utility within the diagnostic setting requires further investigation. AIM: The aim of our study was to test the predictive value of two of these tools, sorting intolerant from tolerant (SIFT) and polymorphism phenotyping (PolyPhen), in a set of 141 missense variants (131 pathogenic, 8 benign) identified in the ABCC8, GCK, and KCNJ11 genes. METHODS: Sixty-six of the mutations caused a gain of protein function, while 67 were loss-of-function mutations. The evolutionary conservation at each residue was also investigated using multiple sequence alignments from the UCSC genome browser. RESULTS: The sensitivity of SIFT and PolyPhen was reasonably high (69% and 68%, respectively), but their specificity was low (13% and 16%). Both programs were significantly better at predicting loss-of-function mutations than gain-of-function mutations (SIFT, p = 0.001; PolyPhen, p < or = 0.0001). The most reliable method for assessing the likely pathogenicity of a missense variant was to investigate the degree of conservation at the affected residue. Eighty-eight percent of the mutations affected highly conserved residues, while all of the benign variants occurred at residues that were polymorphic across multiple species. CONCLUSIONS: Although SIFT and PolyPhen may be useful in prioritizing changes that are likely to cause a loss of protein function, their low specificity means that their predictions should be interpreted with caution and further evidence to support/refute pathogenicity should be sought before reporting novel missense changes.
CONTEXT: The interpretation of novel missense variants is a challenge with increasing numbers of such variants being identified and a responsibility to report the findings in the context of all available scientific evidence. Various in silico bioinformatic tools have been developed that predict the likely pathogenicity of missense variants; however, their utility within the diagnostic setting requires further investigation. AIM: The aim of our study was to test the predictive value of two of these tools, sorting intolerant from tolerant (SIFT) and polymorphism phenotyping (PolyPhen), in a set of 141 missense variants (131 pathogenic, 8 benign) identified in the ABCC8, GCK, and KCNJ11 genes. METHODS: Sixty-six of the mutations caused a gain of protein function, while 67 were loss-of-function mutations. The evolutionary conservation at each residue was also investigated using multiple sequence alignments from the UCSC genome browser. RESULTS: The sensitivity of SIFT and PolyPhen was reasonably high (69% and 68%, respectively), but their specificity was low (13% and 16%). Both programs were significantly better at predicting loss-of-function mutations than gain-of-function mutations (SIFT, p = 0.001; PolyPhen, p < or = 0.0001). The most reliable method for assessing the likely pathogenicity of a missense variant was to investigate the degree of conservation at the affected residue. Eighty-eight percent of the mutations affected highly conserved residues, while all of the benign variants occurred at residues that were polymorphic across multiple species. CONCLUSIONS: Although SIFT and PolyPhen may be useful in prioritizing changes that are likely to cause a loss of protein function, their low specificity means that their predictions should be interpreted with caution and further evidence to support/refute pathogenicity should be sought before reporting novel missense changes.
Authors: Robert P Milius; Michael Heuer; Daniel Valiga; Kathryn J Doroschak; Caleb J Kennedy; Yung-Tsi Bolon; Joel Schneider; Jane Pollack; Hwa Ran Kim; Nezih Cereb; Jill A Hollenbach; Steven J Mack; Martin Maiers Journal: Hum Immunol Date: 2015-08-28 Impact factor: 2.850
Authors: Ana I Hernandez Cordero; Natalia M Gonzales; Clarissa C Parker; Greta Sokolof; David J Vandenbergh; Riyan Cheng; Mark Abney; Andrew Sko; Alex Douglas; Abraham A Palmer; Jennifer S Gregory; Arimantas Lionikas Journal: Am J Hum Genet Date: 2019-11-21 Impact factor: 11.025
Authors: Rodrigo Dienstmann; Fei Dong; Darrell Borger; Dora Dias-Santagata; Leif W Ellisen; Long P Le; A John Iafrate Journal: Mol Oncol Date: 2014-04-04 Impact factor: 6.603
Authors: Lesley-Ann Sutton; Viktor Ljungström; Larry Mansouri; Emma Young; Diego Cortese; Veronika Navrkalova; Jitka Malcikova; Alice F Muggen; Martin Trbusek; Panagiotis Panagiotidis; Frederic Davi; Chrysoula Belessi; Anton W Langerak; Paolo Ghia; Sarka Pospisilova; Kostas Stamatopoulos; Richard Rosenquist Journal: Haematologica Date: 2014-12-05 Impact factor: 9.941
Authors: Robert R McWilliams; Eric D Wieben; Kari G Chaffee; Samuel O Antwi; Leon Raskin; Olufunmilayo I Olopade; Donghui Li; W Edward Highsmith; Gerardo Colon-Otero; Lauren G Khanna; Jennifer B Permuth; Janet E Olson; Harold Frucht; Jeanine Genkinger; Wei Zheng; William J Blot; Lang Wu; Luciana L Almada; Martin E Fernandez-Zapico; Hugues Sicotte; Katrina S Pedersen; Gloria M Petersen Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-07-23 Impact factor: 4.254
Authors: Neil E Bowles; Chuanchau J Jou; Cammon B Arrington; Brett J Kennedy; Aubree Earl; Norisada Matsunami; Lindsay L Meyers; Susan P Etheridge; Elizabeth V Saarel; Steven B Bleyl; H Joseph Yost; Mark Yandell; Mark F Leppert; Martin Tristani-Firouzi; Peter J Gruber Journal: Am J Med Genet A Date: 2015-08-18 Impact factor: 2.802